stoxline Quote Chart Rank Option Currency Glossary
  
(MEDS)
  0 (0%)    11-11 19:27
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2024-12-20 4:39:36 PM
Short term     
Mid term     
Targets 6-month :  9.79 1-year :  11.15
Resists First :  8.38 Second :  9.55
Pivot price 8.07
Supports First :  6.5 Second :  5.4
MAs MA(5) :  8.08 MA(20) :  8.04
MA(100) :  8.97 MA(250) :  8.55
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  47.1 D(3) :  54.4
RSI RSI(14): 46
52-week High :  44.56 Low :  3.69
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MEDS ] has closed below the lower bollinger band by 13.5%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ MEDS ] is to continue within current trading range. It is unclear right now based on current values. 84.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 68 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 8.42 - 8.47 8.47 - 8.51
Low: 7.42 - 7.48 7.48 - 7.52
Close: 7.46 - 7.55 7.55 - 7.61
Company Description

Headline News

Tue, 11 Nov 2025
Mixing these 5 common foods with Diabetes meds could be a big mistake, experts say avoid these - The Economic Times

Tue, 11 Nov 2025
Suspect accused of killing college pre-med student has a criminal history: court records - Fox News

Tue, 11 Nov 2025
Below Deck Med's Chef Josh Bingham Pitches Cooking Spinoff Show - Us Weekly

Tue, 11 Nov 2025
AG Marshall alleges med spa provided unapproved weight loss drugs - Alabama Political Reporter

Mon, 10 Nov 2025
Effectiveness of anti-clotting meds after stent placement varied in people with diabetes - Medical Xpress

Mon, 10 Nov 2025
Educational seminar weighs risks/benefits of GLP-1 meds - Sun Community News

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 2 (M)
Held by Insiders 734540 (%)
Held by Institutions 0 (%)
Shares Short 43 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.204e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 56.6 %
Operating Margin -7 %
Return on Assets (ttm) 998.7 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 7.45e+006 %
Gross Profit (p.s.) 0
Sales Per Share 4.44
EBITDA (p.s.) -6.83
Qtrly Earnings Growth -24.4 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 1.69
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 15000
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android